Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 163

Similar articles for PubMed (Select 24734285)

1.

Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy.

Aasbjerg K, Backer V, Lund G, Holm J, Nielsen NC, Holse M, Wagtmann VR, Würtzen PA.

Clin Exp Allergy. 2014 Mar;44(3):417-28.

PMID:
24734285
2.
3.

Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.

Gadermaier E, Staikuniene J, Scheiblhofer S, Thalhamer J, Kundi M, Westritschnig K, Swoboda I, Flicker S, Valenta R.

Allergy. 2011 Sep;66(9):1174-82. doi: 10.1111/j.1398-9995.2011.02592.x. Epub 2011 Apr 11.

PMID:
21480924
4.

Heterogeneity of antibody responses among clinical responders during grass pollen sublingual immunotherapy.

Baron-Bodo V, Horiot S, Lautrette A, Chabre H, Drucbert AS, Danzé PM, Sénéchal H, Peltre G, Galvain S, Zeldin RK, Horak F, Moingeon P.

Clin Exp Allergy. 2013 Dec;43(12):1362-73. doi: 10.1111/cea.12187.

PMID:
24261946
5.

Immunologic effects and tolerability profile of in-season initiation of a standardized-quality grass allergy immunotherapy tablet: a phase III, multicenter, randomized, double-blind, placebo-controlled trial in adults with grass pollen-induced rhinoconjunctivitis.

Reich K, Gessner C, Kroker A, Schwab JA, Pohl W, Villesen H, Wüstenberg E, Emminger W.

Clin Ther. 2011 Jul;33(7):828-40. doi: 10.1016/j.clinthera.2011.06.006. Epub 2011 Jul 7.

PMID:
21741092
6.

Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy.

Van Overtvelt L, Baron-Bodo V, Horiot S, Moussu H, Ricarte C, Horak F, Zieglmayer P, Zieglmayer R, Montagut A, Galvain S, de Beaumont O, Le Gall M, Moingeon P.

Allergy. 2011 Dec;66(12):1530-7. doi: 10.1111/j.1398-9995.2011.02696.x. Epub 2011 Aug 29.

PMID:
21883279
7.

Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.

Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Di Lorenzo G.

J Allergy Clin Immunol. 2012 Nov;130(5):1097-1107.e2. doi: 10.1016/j.jaci.2012.08.012. Epub 2012 Sep 27.

PMID:
23021885
8.

Functional rather than immunoreactive levels of IgG4 correlate closely with clinical response to grass pollen immunotherapy.

Shamji MH, Ljørring C, Francis JN, Calderon MA, Larché M, Kimber I, Frew AJ, Ipsen H, Lund K, Würtzen PA, Durham SR.

Allergy. 2012 Feb;67(2):217-26. doi: 10.1111/j.1398-9995.2011.02745.x. Epub 2011 Nov 14.

PMID:
22077562
9.

Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells.

Scadding GW, Shamji MH, Jacobson MR, Lee DI, Wilson D, Lima MT, Pitkin L, Pilette C, Nouri-Aria K, Durham SR.

Clin Exp Allergy. 2010 Apr;40(4):598-606. doi: 10.1111/j.1365-2222.2010.03462.x. Epub 2010 Feb 22.

PMID:
20184605
10.
11.

Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.

Gadermaier E, Flicker S, Aberer W, Egger C, Reider N, Focke M, Vrtala S, Kundi M, Valenta R.

Int Arch Allergy Immunol. 2010;151(1):17-27. doi: 10.1159/000232567. Epub 2009 Aug 6.

PMID:
19672093
12.

Dose dependence of immunological response to sublingual immunotherapy.

Marcucci F, Sensi L, Di Cara G, Incorvaia C, Frati F.

Allergy. 2005 Jul;60(7):952-6.

PMID:
15932387
14.

The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.

Keskin O, Tuncer A, Adalioglu G, Sekerel BE, Saçkesen C, Kalayci O.

Pediatr Allergy Immunol. 2006 Sep;17(6):396-407.

PMID:
16925684
15.

Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation.

Suárez-Fueyo A, Ramos T, Galán A, Jimeno L, Wurtzen PA, Marin A, de Frutos C, Blanco C, Carrera AC, Barber D, Varona R.

J Allergy Clin Immunol. 2014 Jan;133(1):130-8.e1-2. doi: 10.1016/j.jaci.2013.09.043. Epub 2013 Nov 28.

PMID:
24290282
16.

A pre-seasonal birch/hazel sublingual immunotherapy can improve the outcome of grass pollen injective treatment in bisensitized individuals. A case-referent, two-year controlled study.

Cirla AM, Cirla PE, Parmiani S, Pecora S.

Allergol Immunopathol (Madr). 2003 Jan-Feb;31(1):31-43. Erratum in: Allergol Immunopathol (Madr). 2003 May-Jun;31(3):114.

PMID:
12573207
17.

Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet.

Durham SR, Emminger W, Kapp A, Colombo G, de Monchy JG, Rak S, Scadding GK, Andersen JS, Riis B, Dahl R.

J Allergy Clin Immunol. 2010 Jan;125(1):131-8.e1-7. doi: 10.1016/j.jaci.2009.10.035.

PMID:
20109743
18.

Comparison of efficacy, safety and immunologic effects of subcutaneous and sublingual immunotherapy in birch pollinosis: a randomized study.

Mauro M, Russello M, Incorvaia C, Gazzola GB, Di Cara G, Frati F.

Eur Ann Allergy Clin Immunol. 2007 Apr;39(4):119-22.

PMID:
17523385
19.

Short-term preseasonal immunotherapy: is early clinical efficacy related to the basophil response?

Kepil Özdemir S, Sin BA, Güloğlu D, İkincioğulları A, Gençtürk Z, Mısırlıgil Z.

Int Arch Allergy Immunol. 2014;164(3):237-45. doi: 10.1159/000365628. Epub 2014 Aug 21.

PMID:
25170594
20.

Allergen specificity of IgG(4)-expressing B cells in patients with grass pollen allergy undergoing immunotherapy.

James LK, Bowen H, Calvert RA, Dodev TS, Shamji MH, Beavil AJ, McDonnell JM, Durham SR, Gould HJ.

J Allergy Clin Immunol. 2012 Sep;130(3):663-670.e3. doi: 10.1016/j.jaci.2012.04.006. Epub 2012 May 13.

PMID:
22583928
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk